欧普康视 reported revenue of ¥0.87B for the period ended 2026-06-30, -0.6% year on year. Net income was ¥0.25B, a 29.1% net margin on a 69.5% gross margin. The largest revenue line is 硬性接触镜 at 37% of the total. Free cash flow for the period was ¥0.08B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.87B | -0.6% |
| Gross profit | ¥0.60B | — |
| Operating income | ¥0.30B | — |
| Net income | ¥0.25B | -8.7% |
| Gross margin | 69.5% | Net margin 29.1% |
| Revenue Q/Q | -11.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 硬性接触镜 | ¥0.32B | 37.4% |
| 框架镜等其他视光产品及技术服务 | ¥0.21B | 24.3% |
| 医疗服务 | ¥0.19B | 21.9% |
| 护理产品 | ¥0.10B | 12.0% |
| 非视光类产品 | ¥0.03B | 3.9% |
| 其他(补充) | ¥0.00B | 0.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.26B | 30.5% |
| R&D | ¥0.02B | 1.9% |
| SG&A | ¥0.31B | 35.4% |
| Tax & other | ¥0.05B | 6.0% |
| Item | Amount |
|---|---|
| Total assets | ¥6.12B |
| Total liabilities | ¥0.69B |
| Shareholders' equity | ¥5.43B |
| Equity / assets | 88.8% |
| Operating cash flow | ¥0.10B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥0.08B |
| Cash conversion (OCF / net income) | 99% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
利安隆 ・ 吉大通信 ・ 诚迈科技 ・ 雄塑科技 ・ 国瑞科技 ・ 康泰生物 ・ 飞荣达 ・ 立昂技术 ・ 长川科技 ・ 恒锋信息 ・ 金太阳 ・ 拓斯达
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies